Prognostic Utility of the 21-Gene Assay in Hormone Receptor–Positive Operable Breast Cancer Compared With Classical Clinicopathologic Features

PURPOSE: Adjuvant! is a standardized validated decision aid that projects outcomes in operable breast cancer based on classical clinicopathologic features and therapy. Genomic classifiers offer the potential to more accurately identify individuals who benefit from chemotherapy than clinicopathologic...

Full description

Saved in:
Bibliographic Details
Main Authors: Goldstein, Lori J., Gray, Robert, Badve, Sunil, Childs, Barrett H., Yoshizawa, Carl, Rowley, Steve, Shak, Steven, Baehner, Frederick L., Ravdin, Peter M., Davidson, Nancy E., Sledge, George W., Perez, Edith A., Shulman, Lawrence N., Martino, Silvana, Sparano, Joseph A.
Format: Artigo
Language:Inglês
Published: American Society of Clinical Oncology 2008
Subjects:
Breast Cancer
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2654377/
https://ncbi.nlm.nih.gov/pubmed/18678838
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2007.14.4501
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items